J&J MedTech Plans to Discuss Bio Research Deregulation with S. Korea

SEOUL, July 11 (Korea Bizwire) — Johnson & Johnson (J&J) MedTech Korea, the South Korean unit of U.S. pharmaceutical giant J&J SA’s medical devices affiliate, plans to hold discussions on deregulation in the area of bio research with the new Seoul administration under President Yoon Suk-yeol, its country general manager said Monday. The announcement by [...]